Online citations, reference lists, and bibliographies.
← Back to Search

VEGF Profiling And Angiogenesis In Human Microtissues.

J. Kelm, Carlota Diaz Sanchez-Bustamante, E. Ehler, S. Hoerstrup, V. Djonov, L. Ittner, M. Fussenegger
Published 2005 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Owing to its dual impact on tissue engineering (neovascularization of tissue implants) and cancer treatment (prevention of tumor-induced vascularization), management and elucidation of vascularization phenomena remain clinical priorities. Using a variety of primary human cells and (neoplastic) cell lines assembled in microtissues by gravity-enforced self-aggregation in hanging drops we (i) studied size and age-dependent VEGF production of microtissues in comparison to isogenic monolayer cultures, (ii) characterized the self-organization and VEGF-production potential of mixed-cell spheroids, (iii) analyzed VEGF-dependent capillary formation of human umbilical vein endothelial cells (HUVECs) cells coated onto several human primary cell spheroids, and (iv) profiled endostatin action on vascularization in human microtissues. Precise understanding of vascularization in human microtissues may foster advances in clinical tissue implant engineering, tumor treatment, as well as drug discovery and drug-function analysis.
This paper references
10.1089/107632704322791853
Design of artificial myocardial microtissues.
J. Kelm (2004)
10.1002/BIT.10655
Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types.
J. Kelm (2003)
10.1038/nrc1093
Angiogenesis: Tumorigenesis and the angiogenic switch
G. Bergers (2003)
10.1038/nm0603-685
Molecular regulation of vessel maturation
R. Jain (2003)
10.1096/fj.02-1041fje
Cell‐demanded release of VEGF from synthetic, biointeractive cell‐ingrowth matrices for vascularized tissue growth
A. Zisch (2003)
10.1161/01.RES.84.3.298
Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact.
K. Hirschi (1999)
10.1016/J.TIBTECH.2004.02.002
Microscale tissue engineering using gravity-enforced cell assembly.
J. Kelm (2004)
10.1016/S0008-6363(00)00281-9
Molecular mechanisms of blood vessel growth.
E. Conway (2001)
10.1161/01.RES.86.3.286
Intussusceptive angiogenesis: its role in embryonic vascular network formation.
V. Djonov (2000)
10.1038/35025215
Vascular-specific growth factors and blood vessel formation
G. Yancopoulos (2000)
10.1016/S0098-2997(02)00008-0
Principals of neovascularization for tissue engineering.
M. Nomi (2002)
10.1002/CYTO.990140705
Three-dimensional visualization of multi-channel volume data: the amSFP algorithm.
J. M. Messerli (1993)
10.1101/GAD.914801
Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha.
D. A. Elson (2001)
10.1038/nbt1101-1029
Polymeric system for dual growth factor delivery
T. P. Richardson (2001)
10.1042/BA20030124
REVIEW: Synergies of microtissue design, viral transduction and adjustable transgene expression for regenerative medicine
J. Kelm (2004)
Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells.
G. Schuch (2003)
10.1111/j.1749-6632.2002.tb03092.x
Vascular Assembly in Engineered and Natural Tissues
L. Mcintire (2002)
10.1016/S1097-2765(00)80154-9
VEGF gene delivery to muscle: potential role for vasculogenesis in adults.
M. Springer (1998)
10.1101/GAD.934301
Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival.
E. Schipani (2001)
10.1073/pnas.182296499
Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo
K. Jin (2002)
10.1038/87850
The well-tempered vessel
H. Blau (2001)
10.1517/13543784.12.6.933
Angiopoietins in angiogenesis and beyond
S. Tsigkos (2003)
10.1038/labinvest.3780252
In Vitro Models of Vasculogenesis and Angiogenesis
B. Vailhé (2001)
10.1016/S0003-4975(98)00796-6
Fluorescence activated cell sorting: a reliable method in tissue engineering of a bioprosthetic heart valve.
S. Hoerstrup (1998)
10.1016/S0092-8674(01)00518-9
HIF-1, O2, and the 3 PHDs How Animal Cells Signal Hypoxia to the Nucleus
G. Semenza (2001)
10.1146/ANNUREV.PHYSIOL.62.1.649
Endothelial signal integration in vascular assembly.
T. Daniel (2000)
10.1126/SCIENCE.7512751
Requirement of vascular integrin alpha v beta 3 for angiogenesis.
P. Brooks (1994)
10.1038/SCIENTIFICAMERICAN1201-38
Vessels of death or life.
R. K. Jain (2001)
VEGF is required for growth and survival in neonatal mice.
H. Gerber (1999)
10.1038/sj.mn.7800172
Microvascular Remodeling: A Complex Continuum Spanning Angiogenesis to Arteriogenesis
S. Peirce (2003)
10.1083/JCB.109.1.309
Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture
Y. Satō (1989)
10.1096/fj.00-0139com
Blood vessel maturation in a 3‐dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness
T. Korff (2001)
10.1126/SCIENCE.284.5413.489
Functional arteries grown in vitro.
L. Niklason (1999)
10.1007/s00109-002-0380-0
Hypoxia-induced angiogenesis in human hepatocellular carcinoma
Kwang-Rok Kim (2002)
10.1038/8379
Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188
P. Carmeliet (1999)
10.1038/70928
Clinical applications of angiogenic growth factors and their inhibitors
N. Ferrara (1999)
10.1096/fj.00-0490fje
The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing
W. Bloch (2000)
10.1038/415234a
Myocardial gene therapy
J. Isner (2002)
10.1038/421884A
Tissue engineering: The beat goes on
C. Zandonella (2003)
10.1016/S0955-0674(00)00252-0
Adhesion events in angiogenesis.
B. Eliceiri (2001)
10.1016/S0092-8674(00)81848-6
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
M. O'reilly (1997)
10.1038/SCIENTIFICAMERICAN0499-60
Growing new organs.
D. Mooney (1999)
Tensional forces in fibrillar extracellular matrices control directional capillary sprouting.
T. Korff (1999)
10.1038/ni0104-11
Genes tell lymphatics to sprout or not
J. Folkman (2004)
10.1161/01.CIR.102.8.898
VEGF gene delivery to myocardium: deleterious effects of unregulated expression.
R. Lee (2000)
10.1146/ANNUREV.MED.54.101601.152418
Angiogenesis in ischemic and neoplastic disorders.
G. Semenza (2003)
Theory and Practice of Histotechnology
Dezna C. Sheehan (1980)
10.1038/35025220
Angiogenesis in cancer and other diseases
P. Carmeliet (2000)
10.1016/S1044-579X(02)00133-5
Angiogenesis and apoptosis.
J. Folkman (2003)
10.1126/SCIENCE.1069210
Tissue Engineering--Current Challenges and Expanding Opportunities
L. Griffith (2002)
10.1016/J.YEXCR.2003.11.008
Extracellular fragment of brain-specific angiogenesis inhibitor 1 suppresses endothelial cell proliferation by blocking αvβ5 integrin
J. T. Koh (2004)



This paper is referenced by
10.1088/1758-5082/4/2/025004
Human adipose stem cells maintain proliferative, synthetic and multipotential properties when suspension cultured as self-assembling spheroids.
S. Kapur (2012)
10.1007/978-1-59745-443-8_9
In vitro vascularization of human connective microtissues.
J. Kelm (2007)
10.1515/rnam-2018-0019
Analysis of anticancer efficiency of combined fractionated radiotherapy and antiangiogenic therapy via mathematical modelling
M. Kuznetsov (2018)
10.1007/978-3-030-12270-6_15
In Vitro Assays Used to Analyse Vascular Cell Functions
A. Türkcan (2019)
10.1007/s00262-016-1927-1
A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents
S. Herter (2016)
10.1021/mp5000604
Development of a magnetic 3D spheroid platform with potential application for high-throughput drug screening.
W. Guo (2014)
10.1016/j.jbiotec.2010.03.002
A novel concept for scaffold-free vessel tissue engineering: self-assembly of microtissue building blocks.
J. Kelm (2010)
10.1016/j.addr.2014.10.025
Cell based advanced therapeutic medicinal products for bone repair: Keep it simple?
J. Leijten (2015)
10.1002/jgm.960
Adenoviral vector platform for transduction of constitutive and regulated tricistronic or triple‐transcript transgene expression in mammalian cells and microtissues
V. Gonzalez-Nicolini (2006)
10.1002/biot.201400494
Isothermal microcalorimetry accurately detects bacteria, tumorous microtissues, and parasitic worms in a label-free well-plate assay
O. Braissant (2015)
10.1002/BIT.20679
Heterologous protein production capacity of mammalian cells cultivated as monolayers and microtissues
C. D. Sánchez-Bustamante (2006)
10.1016/j.addr.2010.02.003
Scaffold-free cell delivery for use in regenerative medicine.
J. Kelm (2010)
10.1002/9781118851647.CH2
Gravity‐enforced microtissue engineering
Randy Strube (2017)
10.1177/1087057113499071
A High-Throughput–Compatible 3D Microtissue Co-Culture System for Phenotypic RNAi Screening Applications
Claudio R. Thoma (2013)
10.3109/10717544.2010.509357
Hyaluronic acid/Chitosan nanoparticles as delivery vehicles for VEGF and PDGF-BB
Yolanda Parajó (2010)
10.1134/S0006350919020118
The Influence of Chemotherapy on the Progression of a Biclonal Tumor: Analysis Using Mathematical Modeling
M. Kuznetsov (2019)
10.1016/j.addr.2013.12.004
Cell therapy, 3D culture systems and tissue engineering for cardiac regeneration.
M. Emmert (2014)
10.1002/jcb.28926
Coculture with noncardiac cells promoted maturation of human stem cell–derived cardiomyocyte microtissues
Fahimeh Varzideh (2019)
10.1371/journal.pone.0136681
Scaffold-Free Tubular Tissues Created by a Bio-3D Printer Undergo Remodeling and Endothelialization when Implanted in Rat Aortae
M. Itoh (2015)
10.1016/j.ejps.2010.09.008
PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors.
Yolanda Parajó (2010)
10.1517/17460441.2013.852181
3D in vitro tissue models and their potential for drug screening
Lauren Kimlin (2013)
10.1016/j.archoralbio.2018.02.008
A comprehensive analysis of human dental pulp cell spheroids in a three-dimensional pellet culture system.
Siyuan Zhang (2018)
10.3929/ethz-a-009756864
Computational modeling and simulation of cellular growth and migration in angiogenesis
Johannes Florian Milde (2013)
10.1016/J.JDERMSCI.2006.01.002
Human endothelial progenitor cells induce capillary-like tube formation in skin equivalents.
Hyun-joo Cho (2006)
10.1007/978-1-59745-443-8_15
Myocardial restoration and tissue engineering of heart structures.
T. Kofidis (2007)
10.1089/scd.2013.0119
Grafts enriched with subamnion-cord-lining mesenchymal stem cell angiogenic spheroids induce post-ischemic myocardial revascularization and preserve cardiac function in failing rat hearts.
E. Martinez (2013)
10.1016/j.biomaterials.2013.04.034
Human stem cell-based three-dimensional microtissues for advanced cardiac cell therapies.
M. Emmert (2013)
10.1016/j.cellbi.2008.07.020
Molecular and ultrastructural characterization of endothelial cells differentiated from human bone marrow mesenchymal stem cells
M. Jazayeri (2008)
10.1002/adhm.201901831
Scaffold-Free Bio-3D Printing Using Spheroids as "Bio-Inks" for Tissue (Re-)Construction and Drug Response Tests.
Daiki Murata (2020)
10.1152/JAPPLPHYSIOL.00800.2006
VEGF gradients, receptor activation, and sprout guidance in resting and exercising skeletal muscle.
F. Mac Gabhann (2007)
10.1089/107632704322791853
Design of artificial myocardial microtissues.
J. Kelm (2004)
10.1016/j.biomaterials.2017.07.021
Inspiration from heart development: Biomimetic development of functional human cardiac organoids.
D. Richards (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar